Brief: Orchard Therapeutics Secures Partnerships To Broaden Access To LibmeldyTM For Eligible Patients In Middle East & Turkey
19/01/2021 13:29
Jan 19 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS SECURES PARTNERSHIPS TO BROADEN
ACCESS TO
LIBMELDYTM FOR ELIGIBLE PATIENTS IN MIDDLE EAST & TURKEY
* ORCHARD THERAPEUTICS - ANNOUNCED PLANS TO EXTEND
COMMERCIAL
REACH IN MIDDLE EAST AND TURKEY THROUGH AGREEMENTS WITH GENPHARM
SERVICES AND GEN
* ORCHARD THERAPEUTICS - PARTNERSHIPS WILL EXPAND ACCESS TO
LIBMELDY FOR PATIENTS LIVING IN SAUDI ARABIA, KUWAIT, UAE,
QATAR, BAHRAIN, OMAN AND TURKEY
Source text for Eikon: ID:nGNX61Q3JS
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln